Improved survival of men with metastatic prostate cancer treated with androgen deprivation therapy plus radiotherapy to the prostate

Int J Urol. 2017 Dec;24(12):863-865. doi: 10.1111/iju.13479. Epub 2017 Oct 23.

Authors

Akihiro Yano¹, Makoto Kagawa¹, Hideki Takeshita¹, Yohei Okada¹, Makoto Morozumi¹, Satoru Kawakami¹

Affiliation

¹ Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.

PMID: 29057511
DOI: 10.1111/iju.13479

No abstract available

MeSH terms

Aged
Aged, 80 and over
Androgen Antagonists / therapeutic use*
Combined Modality Therapy
Humans
Japan / epidemiology
Male
Middle Aged
Neoplasm Metastasis
Prostatic Neoplasms / mortality*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / therapy*
Radiotherapy / methods*
Survival Analysis

Substances

Androgen Antagonists